Skip to main content

Vaccine Adjuvants Market Analysis as per the Latest COVID-19 Impact

The global vaccine adjuvants market consists of human and veterinary adjuvants that are used to improve the efficacy of vaccines. This market is driven by several factors such as increasing government funding for research, high prevalence of diseases, expanding biotechnology and biopharmaceutical industries, and growing focus on the prevention of diseases.

The global vaccine adjuvants market is expected to reach USD 769.4 Million by 2021 from USD 467.0 Million in 2016, at a CAGR of 10.5%.

What Drives the Market?

1. Increasing Use of Adjuvants in Vaccine
2. High Prevalence of Infectious and Zoonotic Diseases
3. Increase in Livestock and Instances of Diseases
4. Increasing Focus on Immunization Programs From Various Government Bodies
5. Technological Advancements in Aluminum Hydroxide-Based Adjuvants

The research applications segment is expected to account for the largest share of the market during the forecast period. The human vaccine adjuvants segment is expected to account for the largest share of the global market in 2016 and is expected to have a higher growth rate in the application category segment.

Get a sample PDF copy of the Report @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=152603894


The global market is broadly classified into product type, route of administration, disease type, applications, and application categories.

On the basis of product type, the vaccine adjuvants market is segmented into pathogen components, adjuvant emulsions, particulate adjuvants, combination adjuvants, and others. The particulate adjuvants segment is expected to account for the largest share of the global market in 2016.

Target Audience for this Report:

# Vaccine adjuvants manufacturers and suppliers
# Academic research institutes
# Biopharmaceutical and biotechnology companies
# Research and development (R&D) companies
# Business research and consulting service providers
# Medical research laboratories
# Academic medical centers and universities

On the basis of disease type, the vaccine adjuvants market is segmented into infectious diseases, cancer, and others. The infectious diseases segment is expected to account for the largest share of the global market in 2016. Factors such as high prevalence of infectious diseases, government & company initiatives, and high prevalence of cancer cases are expected to drive market growth in the coming years.

For getting 10% customization Please click here @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=152603894

The geographical regions mapped in the report are:
1. North America
2. Europe
3. Asia-Pacific
4. Rest of the World (RoW)

The vaccine adjuvants market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). However, Asia is projected to grow at the highest CAGR during the forecast period. Growth in the North American segment is primarily driven by the increasing geriatric population and rising incidences of diseases in the North American countries

Some key players mentioned in the research report are:

Brenntag Biosector (Denmark), CSL Limited (Australia), SEPPIC (France), Agenus, Inc. (U.S.), Novavax, Inc. (U.S.), SPI Pharma, Inc. (U.S.), Invivogen (U.S.), Avanti Polar Lipids, Inc. (U.S.), MVP Laboratories, Inc. (U.S.), and OZ Biosciences (France).

Comments

Popular posts from this blog

Potential Impact Of COVID-19 On Walking Assist Devices Market

The global market is expected to witness growth in the coming years, owing to factors such as the increase in the number of initiatives undertaken by governments of various countries to ensure availability of walking assist devices to a huge consumer base, rise in aging population, and increasing incidences of Debilitating Neurological Diseases & Injuries. The  global walking assist devices market  is expected to reach $6.57 Billion by 2020, at a CAGR of 3.9% from 2015 to 2020. Walking Assist Devices Market by Product Type (Gait Belts & Lift Vests, Canes, Crutches, Walker, Wheelchairs, Power Scooters), and Region (North America, Europe, Asia-Pacific and ROW) – Global Forecast to 2020 Download PDF Brochure :  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=98811670 Global Walking Assist Devices Market is Segmented on: 1. Product Type 2. Geography Product Type Based on product, the global market is classified into gaits belts and lift vests, canes, crutches,...

Ambulatory Surgical Centers Market To Reach USD 7.2 Billion By 2025 – Increasing Investment In Supply Chain Management

  What This Report Will Provide? The study involved four major activities in estimating the size of the Ambulatory Surgical Centers market. Exhaustive secondary research was done to collect information on the adoption of different technologies and their regional adoption trends. Industry experts further validated the data obtained through secondary research through primary research. Furthermore, the market size estimates and forecast provided in this study are derived through a mix of the bottom-up approach (country-level data for outpatient surgical procedures) and top-down approach (assessment of utilization/adoption/penetration trends, by product and services, components, and specialty type). After that, market breakdown and data triangulation methods were used to estimate the market size of segments and subsegments. Expected Revenue Growth : [176 Pages Report] The  Ambulatory surgical centers market  is projected to reach USD 7.2 billion by 2025 from 2.1 billion in 20...